• レポートコード:QY20ST-06595 • 出版社/出版日:QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態:英文、PDF、136ページ • 納品方法:Eメール(受注後2~3営業日) • 産業分類:医療機器・消耗品 |
Single User | ¥560,000 (USD4,000) | ▷ お問い合わせ |
Multi User | ¥840,000 (USD6,000) | ▷ お問い合わせ |
Enterprise License | ¥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、世界の内部神経調節装置市場について種類別(深部脳刺激装置、仙骨神経刺激装置、脊髄刺激装置、迷走神経刺激装置、その他)、用途別(病院、クリニック、在宅医療)、地域別(北米、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・内部神経調節装置市場の概要 ・世界の主要地域別内部神経調節装置市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の内部神経調節装置市場規模2015-2026:種類別(深部脳刺激装置、仙骨神経刺激装置、脊髄刺激装置、迷走神経刺激装置、その他) ・世界の内部神経調節装置市場規模2015-2026:用途別(病院、クリニック、在宅医療) ・内部神経調節装置の北米市場規模2015-2020 ・内部神経調節装置のヨーロッパ市場規模2015-2020 ・内部神経調節装置の中国市場規模2015-2020 ・内部神経調節装置の日本市場規模2015-2020 ・内部神経調節装置の東南アジア市場規模2015-2020 ・内部神経調節装置のインド市場規模2015-2020 ・主要プレイヤーの企業情報:事業概要・売上・企業動向 ・内部神経調節装置の製造コスト分析 ・販売チャネル、流通業者、顧客 ・内部神経調節装置の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Internal Neuromodulation Device Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Internal Neuromodulation Device market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Internal neuromodulation devices directly act upon nerves. It is the technology known for alteration of nerve activity directly to a target area by sending electrical or pharmaceutical agents directly to a target area.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Internal Neuromodulation Device market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Internal Neuromodulation Device industry.
Based on our recent survey, we have several different scenarios about the Internal Neuromodulation Device YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Internal Neuromodulation Device will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Internal Neuromodulation Device market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Internal Neuromodulation Device market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Internal Neuromodulation Device market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Internal Neuromodulation Device market. The report also includes nautical information, where it shows Internal Neuromodulation Device market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Internal Neuromodulation Device market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Internal Neuromodulation Device market.
Geographical Analysis:
Based on region, the global Internal Neuromodulation Device market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Internal Neuromodulation Device market are
Medtronic
LivaNova
Boston Scientific
EnteroMedics
BioControl Medical
Bioness
Nevro
…
Segment by Type
Deep Brain Stimulators
Sacral Nerve Stimulators
Spinal Cord Stimulators
Vagus Nerve Stimulators
Others
Segment by Application
Hospitals
Clinics
Home Healthcare
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Internal Neuromodulation Device market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Internal Neuromodulation Device market.
• The market share of the global Internal Neuromodulation Device market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Internal Neuromodulation Device market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Internal Neuromodulation Device market.
1 Internal Neuromodulation Device Market Overview
1.1 Internal Neuromodulation Device Product Scope
1.2 Internal Neuromodulation Device Segment by Type
1.2.1 Global Internal Neuromodulation Device Sales by Type (2020-2026)
1.2.2 Deep Brain Stimulators
1.2.3 Sacral Nerve Stimulators
1.2.4 Spinal Cord Stimulators
1.2.5 Vagus Nerve Stimulators
1.2.6 Others
1.3 Internal Neuromodulation Device Segment by Application
1.3.1 Global Internal Neuromodulation Device Sales Comparison by Application (2020-2026)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Healthcare
1.4 Internal Neuromodulation Device Market Estimates and Forecasts (2015-2026)
1.4.1 Global Internal Neuromodulation Device Sales Growth Rate (2015-2026)
1.4.2 Global Internal Neuromodulation Device Revenue and Growth Rate (2015-2026)
1.4.3 Global Internal Neuromodulation Device Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Internal Neuromodulation Device Industry Impact
1.5.1 How the Covid-19 is Affecting the Internal Neuromodulation Device Industry
1.5.1.1 Internal Neuromodulation Device Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Internal Neuromodulation Device Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Internal Neuromodulation Device Players to Combat Covid-19 Impact
2 Internal Neuromodulation Device Estimate and Forecast by Region
2.1 Global Internal Neuromodulation Device Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Internal Neuromodulation Device Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Internal Neuromodulation Device Sales Market Share by Region (2015-2020)
2.2.2 Global Internal Neuromodulation Device Revenue Market Share by Region (2015-2020)
2.3 Global Internal Neuromodulation Device Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Internal Neuromodulation Device Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Internal Neuromodulation Device Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Internal Neuromodulation Device Estimates and Projections (2015-2026)
2.4.2 Europe Internal Neuromodulation Device Estimates and Projections (2015-2026)
2.4.3 China Internal Neuromodulation Device Estimates and Projections (2015-2026)
2.4.4 Japan Internal Neuromodulation Device Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Internal Neuromodulation Device Estimates and Projections (2015-2026)
2.4.6 India Internal Neuromodulation Device Estimates and Projections (2015-2026)
3 Global Internal Neuromodulation Device Competition Landscape by Players
3.1 Global Top Internal Neuromodulation Device Players by Sales (2015-2020)
3.2 Global Top Internal Neuromodulation Device Players by Revenue (2015-2020)
3.3 Global Internal Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Internal Neuromodulation Device as of 2019)
3.4 Global Internal Neuromodulation Device Average Price by Company (2015-2020)
3.5 Manufacturers Internal Neuromodulation Device Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Internal Neuromodulation Device Players (Opinion Leaders)
4 Global Internal Neuromodulation Device Market Size by Type
4.1 Global Internal Neuromodulation Device Historic Market Review by Type (2015-2020)
4.1.1 Global Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
4.1.2 Global Internal Neuromodulation Device Revenue Market Share by Type (2015-2020)
4.1.3 Global Internal Neuromodulation Device Price by Type (2014-2020)
4.2 Global Internal Neuromodulation Device Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Internal Neuromodulation Device Sales Forecast by Type (2021-2026)
4.2.2 Global Internal Neuromodulation Device Revenue Forecast by Type (2021-2026)
4.2.3 Global Internal Neuromodulation Device Price Forecast by Type (2021-2026)
5 Global Internal Neuromodulation Device Market Size by Application
5.1 Global Internal Neuromodulation Device Historic Market Review by Application (2015-2020)
5.1.1 Global Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
5.1.2 Global Internal Neuromodulation Device Revenue Market Share by Application (2015-2020)
5.1.3 Global Internal Neuromodulation Device Price by Application (2015-2020)
5.2 Global Internal Neuromodulation Device Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Internal Neuromodulation Device Sales Forecast by Application (2021-2026)
5.2.2 Global Internal Neuromodulation Device Revenue Forecast by Application (2021-2026)
5.2.3 Global Internal Neuromodulation Device Price Forecast by Application (2021-2026)
3 North America Internal Neuromodulation Device Market Facts & Figures
3.2 North America Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
3.3 North America Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
3.4 North America Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
4 Europe Internal Neuromodulation Device Market Facts & Figures
4.2 Europe Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
4.3 Europe Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
4.4 Europe Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
5 China Internal Neuromodulation Device Market Facts & Figures
5.2 China Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
5.3 China Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
5.4 China Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
6 Japan Internal Neuromodulation Device Market Facts & Figures
6.2 Japan Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
6.3 Japan Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
6.4 Japan Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
7 Southeast Asia Internal Neuromodulation Device Market Facts & Figures
7.2 Southeast Asia Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
8 India Internal Neuromodulation Device Market Facts & Figures
8.2 India Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
8.3 India Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
8.4 India Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Internal Neuromodulation Device Business
12.1 Medtronic
12.1.1 Medtronic Internal Neuromodulation Device Corporation Information
12.1.2 Medtronic Internal Neuromodulation Device Business Overview and Total Revenue
12.1.3 Medtronic Internal Neuromodulation Device Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Medtronic Internal Neuromodulation Device Products Offered
12.1.5 Medtronic Recent Development
12.2 LivaNova
12.2.1 LivaNova Internal Neuromodulation Device Corporation Information
12.2.2 LivaNova Internal Neuromodulation Device Business Overview and Total Revenue
12.2.3 LivaNova Internal Neuromodulation Device Sales, Revenue and Gross Margin (2015-2020)
12.2.4 LivaNova Internal Neuromodulation Device Products Offered
12.2.5 LivaNova Recent Development
12.3 Boston Scientific
12.3.1 Boston Scientific Internal Neuromodulation Device Corporation Information
12.3.2 Boston Scientific Internal Neuromodulation Device Business Overview and Total Revenue
12.3.3 Boston Scientific Internal Neuromodulation Device Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boston Scientific Internal Neuromodulation Device Products Offered
12.3.5 Boston Scientific Recent Development
12.4 EnteroMedics
12.4.1 EnteroMedics Internal Neuromodulation Device Corporation Information
12.4.2 EnteroMedics Internal Neuromodulation Device Business Overview and Total Revenue
12.4.3 EnteroMedics Internal Neuromodulation Device Sales, Revenue and Gross Margin (2015-2020)
12.4.4 EnteroMedics Internal Neuromodulation Device Products Offered
12.4.5 EnteroMedics Recent Development
12.5 BioControl Medical
12.5.1 BioControl Medical Internal Neuromodulation Device Corporation Information
12.5.2 BioControl Medical Internal Neuromodulation Device Business Overview and Total Revenue
12.5.3 BioControl Medical Internal Neuromodulation Device Sales, Revenue and Gross Margin (2015-2020)
12.5.4 BioControl Medical Internal Neuromodulation Device Products Offered
12.5.5 BioControl Medical Recent Development
12.6 Bioness
12.6.1 Bioness Internal Neuromodulation Device Corporation Information
12.6.2 Bioness Internal Neuromodulation Device Business Overview and Total Revenue
12.6.3 Bioness Internal Neuromodulation Device Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Bioness Internal Neuromodulation Device Products Offered
12.6.5 Bioness Recent Development
12.7 Nevro
12.7.1 Nevro Internal Neuromodulation Device Corporation Information
12.7.2 Nevro Internal Neuromodulation Device Business Overview and Total Revenue
12.7.3 Nevro Internal Neuromodulation Device Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Nevro Internal Neuromodulation Device Products Offered
12.7.5 Nevro Recent Development
…
13 Internal Neuromodulation Device Manufacturing Cost Analysis
13.1 Internal Neuromodulation Device Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Internal Neuromodulation Device
13.4 Internal Neuromodulation Device Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Internal Neuromodulation Device Distributors List
14.3 Internal Neuromodulation Device Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Internal Neuromodulation Device Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Internal Neuromodulation Device Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Internal Neuromodulation Device Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Internal Neuromodulation Device Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Internal Neuromodulation Device Players to Combat Covid-19 Impact
Table 8. Global Market Internal Neuromodulation Device Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Internal Neuromodulation Device Sales (K Units) by Region (2015-2020)
Table 10. Global Internal Neuromodulation Device Sales Market Share by Region (2015-2020)
Table 11. Global Internal Neuromodulation Device Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Internal Neuromodulation Device Revenue Share by Region (2015-2020)
Table 13. Global Internal Neuromodulation Device Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Internal Neuromodulation Device Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Internal Neuromodulation Device Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Internal Neuromodulation Device Revenue Share Forecast by Region (2021-2026)
Table 17. Global Internal Neuromodulation Device (K Units) of Key Companies (2015-2020)
Table 18. Global Internal Neuromodulation Device Sales Share by Company (2015-2020)
Table 19. Global Internal Neuromodulation Device Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Internal Neuromodulation Device Revenue Share by Company (2015-2020)
Table 21. Global Internal Neuromodulation Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Internal Neuromodulation Device as of 2019)
Table 22. Global Internal Neuromodulation Device Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Internal Neuromodulation Device Manufacturing Sites and Area Served
Table 24. Manufacturers Internal Neuromodulation Device Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Internal Neuromodulation Device Players
Table 27. Global Internal Neuromodulation Device Sales (K Units) by Type (2015-2020)
Table 28. Global Internal Neuromodulation Device Sales Share by Type (2015-2020)
Table 29. Global Internal Neuromodulation Device Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Internal Neuromodulation Device Price (K Units) by Type (2015-2020)
Table 31. Global Internal Neuromodulation Device Sales Share by Type (2021-2026)
Table 32. Global Internal Neuromodulation Device Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Internal Neuromodulation Device Revenue Share by Type (2021-2026)
Table 34. Global Internal Neuromodulation Device Price (K Units) by Type (2021-2026)
Table 35. Global Internal Neuromodulation Device Sales (K Units) by Application (2015-2020)
Table 36. Global Internal Neuromodulation Device Sales Share by Application (2015-2020)
Table 37. Global Internal Neuromodulation Device Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Internal Neuromodulation Device Price (K Units) by Application (2015-2020)
Table 39. Global Internal Neuromodulation Device Sales (K Units) by Application (2021-2026)
Table 40. Global Internal Neuromodulation Device Sales Share by Application (2021-2026)
Table 41. Global Internal Neuromodulation Device Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Internal Neuromodulation Device Revenue Share by Application (2021-2026)
Table 43. Global Internal Neuromodulation Device Price (K Units) by Application (2021-2026)
Table 44. United States Internal Neuromodulation Device Sales (K Units) by Company (2015-2020)
Table 45. United States Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
Table 46. United States Internal Neuromodulation Device Sales (K Units) by Type (2015-2020)
Table 47. United States Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
Table 48. United States Internal Neuromodulation Device Sales (K Units) by Application (2015-2020)
Table 49. United States Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
Table 50. Europe Internal Neuromodulation Device Sales (K Units) by Company (2015-2020)
Table 51. Europe Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
Table 52. Europe Internal Neuromodulation Device Sales (K Units) by Type (2015-2020)
Table 53. Europe Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
Table 54. Europe Internal Neuromodulation Device Sales (K Units) by Application (2015-2020)
Table 55. Europe Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
Table 56. China Internal Neuromodulation Device Sales (K Units) by Company (2015-2020)
Table 57. China Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
Table 58. China Internal Neuromodulation Device Sales (K Units) by Type (2015-2020)
Table 59. China Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
Table 60. China Internal Neuromodulation Device Sales (K Units) by Application (2015-2020)
Table 61. China Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
Table 62. Japan Internal Neuromodulation Device Sales (K Units) by Company (2015-2020)
Table 63. Japan Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
Table 64. Japan Internal Neuromodulation Device Sales (K Units) by Type (2015-2020)
Table 65. Japan Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
Table 66. Japan Internal Neuromodulation Device Sales (K Units) by Application (2015-2020)
Table 67. Japan Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Internal Neuromodulation Device Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Internal Neuromodulation Device Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Internal Neuromodulation Device Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
Table 74. India Internal Neuromodulation Device Sales (K Units) by Company (2015-2020)
Table 75. India Internal Neuromodulation Device Sales Market Share by Company (2015-2020)
Table 76. India Internal Neuromodulation Device Sales (K Units) by Type (2015-2020)
Table 77. India Internal Neuromodulation Device Sales Market Share by Type (2015-2020)
Table 78. India Internal Neuromodulation Device Sales (K Units) by Application (2015-2020)
Table 79. India Internal Neuromodulation Device Sales Market Share by Application (2015-2020)
Table 80. Medtronic Corporation Information
Table 81. Medtronic Description and Business Overview
Table 82. Medtronic Internal Neuromodulation Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Medtronic Internal Neuromodulation Device Product
Table 84. Medtronic Recent Development
Table 85. LivaNova Corporation Information
Table 86. LivaNova Description and Business Overview
Table 87. LivaNova Internal Neuromodulation Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. LivaNova Internal Neuromodulation Device Product
Table 89. LivaNova Recent Development
Table 90. Boston Scientific Corporation Information
Table 91. Boston Scientific Description and Business Overview
Table 92. Boston Scientific Internal Neuromodulation Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Boston Scientific Internal Neuromodulation Device Product
Table 94. Boston Scientific Recent Development
Table 95. EnteroMedics Corporation Information
Table 96. EnteroMedics Description and Business Overview
Table 97. EnteroMedics Internal Neuromodulation Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. EnteroMedics Internal Neuromodulation Device Product
Table 99. EnteroMedics Recent Development
Table 100. BioControl Medical Corporation Information
Table 101. BioControl Medical Description and Business Overview
Table 102. BioControl Medical Internal Neuromodulation Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. BioControl Medical Internal Neuromodulation Device Product
Table 104. BioControl Medical Recent Development
Table 105. Bioness Corporation Information
Table 106. Bioness Description and Business Overview
Table 107. Bioness Internal Neuromodulation Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Bioness Internal Neuromodulation Device Product
Table 109. Bioness Recent Development
Table . Nevro Corporation Information
Table . Nevro Description and Business Overview
Table . Nevro Internal Neuromodulation Device Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Nevro Internal Neuromodulation Device Product
Table . Nevro Recent Development
Table 115. Production Base and Market Concentration Rate of Raw Material
Table 116. Key Suppliers of Raw Materials
Table 117. Internal Neuromodulation Device Distributors List
Table 118. Internal Neuromodulation Device Customers List
Table 119. Market Key Trends
Table 120. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 121. Key Challenges
Table 122. Research Programs/Design for This Report
Table 123. Key Data Information from Secondary Sources
Table 124. Key Data Information from Primary Sources
List of Figures
Figure 1. Internal Neuromodulation Device Product Picture
Figure 2. Global Internal Neuromodulation Device Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Internal Neuromodulation Device Market Share by Application in 2020 & 2026
Figure 6. Hospitals Examples
Figure 7. Clinics Examples
Figure 8. Home Healthcare Examples
Figure 9. Global Internal Neuromodulation Device Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Internal Neuromodulation Device Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Internal Neuromodulation Device Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Internal Neuromodulation Device Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Internal Neuromodulation Device Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Internal Neuromodulation Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Internal Neuromodulation Device Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Internal Neuromodulation Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Internal Neuromodulation Device Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Internal Neuromodulation Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Internal Neuromodulation Device Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Internal Neuromodulation Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Internal Neuromodulation Device Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Internal Neuromodulation Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Internal Neuromodulation Device Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Internal Neuromodulation Device Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Internal Neuromodulation Device Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Internal Neuromodulation Device Players Market Share by Revenue in Internal Neuromodulation Device 2015 & 2019
Figure 27. Internal Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Internal Neuromodulation Device Revenue Share by Type (2015-2020)
Figure 29. Global Internal Neuromodulation Device Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Internal Neuromodulation Device Revenue Share by Application (2015-2020)
Figure 31. Global Internal Neuromodulation Device Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Internal Neuromodulation Device Sales Market Share by Type in 2019
Figure 33. United States Internal Neuromodulation Device Sales Market Share by Type in 2019
Figure 34. Europe Internal Neuromodulation Device Sales Market Share by Company in 2019
Figure 35. Europe Internal Neuromodulation Device Sales Market Share by Type in 2019
Figure 36. Europe Internal Neuromodulation Device Sales Market Share by Application in 2019
Figure 37. China Internal Neuromodulation Device Sales Market Share by Company in 2019
Figure 38. China Internal Neuromodulation Device Sales Market Share by Type in 2019
Figure 39. China Internal Neuromodulation Device Sales Market Share by Application in 2019
Figure 40. Japan Internal Neuromodulation Device Sales Market Share by Company in 2019
Figure 41. Japan Internal Neuromodulation Device Sales Market Share by Type in 2019
Figure 42. Japan Internal Neuromodulation Device Sales Market Share by Application in 2019
Figure 43. Southeast Asia Internal Neuromodulation Device Sales Market Share by Company in 2019
Figure 44. Southeast Asia Internal Neuromodulation Device Sales Market Share by Type in 2019
Figure 45. Southeast Asia Internal Neuromodulation Device Sales Market Share by Application in 2019
Figure 46. India Internal Neuromodulation Device Sales Market Share by Company in 2019
Figure 47. India Internal Neuromodulation Device Sales Market Share by Type in 2019
Figure 48. India Internal Neuromodulation Device Sales Market Share by Application in 2019
Figure 49. Medtronic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. LivaNova Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Boston Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. EnteroMedics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. BioControl Medical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Bioness Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Nevro Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Key Raw Materials Price Trend
Figure 57. Manufacturing Cost Structure of Internal Neuromodulation Device
Figure 58. Manufacturing Process Analysis of Internal Neuromodulation Device
Figure 59. Internal Neuromodulation Device Industrial Chain Analysis
Figure 60. Channels of Distribution
Figure 61. Distributors Profiles
Figure 62. Porter's Five Forces Analysis
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed